Clinical trial
Application of Atorvastatin in the TREATment of Patients With Intracranial Unruptured Vertebrobasilar Dissecting Aneurysms
NCT04943783 is registered in ClinicalTrials.gov with Beijing Neurosurgical Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Atorvastatin in the TREATment of Patients With Intracranial Unruptured Vertebrobasilar Dissecting Aneurysms
- Lead sponsor
- Beijing Neurosurgical Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- July 30, 2022
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
dissecting aneurysm of cerebral artery, inflammation vascular, intramural hematomas